JPWO2019135954A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019135954A5
JPWO2019135954A5 JP2020536766A JP2020536766A JPWO2019135954A5 JP WO2019135954 A5 JPWO2019135954 A5 JP WO2019135954A5 JP 2020536766 A JP2020536766 A JP 2020536766A JP 2020536766 A JP2020536766 A JP 2020536766A JP WO2019135954 A5 JPWO2019135954 A5 JP WO2019135954A5
Authority
JP
Japan
Prior art keywords
injectable composition
formula
monolayer vesicles
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020536766A
Other languages
English (en)
Japanese (ja)
Other versions
JP7378401B2 (ja
JP2021508728A (ja
JP2021508728A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/067216 external-priority patent/WO2019135954A1/en
Publication of JP2021508728A publication Critical patent/JP2021508728A/ja
Publication of JPWO2019135954A5 publication Critical patent/JPWO2019135954A5/ja
Publication of JP2021508728A5 publication Critical patent/JP2021508728A5/ja
Priority to JP2023187032A priority Critical patent/JP2024012452A/ja
Application granted granted Critical
Publication of JP7378401B2 publication Critical patent/JP7378401B2/ja
Priority to JP2025060460A priority patent/JP2025106349A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020536766A 2018-01-02 2018-12-21 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 Active JP7378401B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023187032A JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862612893P 2018-01-02 2018-01-02
US62/612,893 2018-01-02
PCT/US2018/067216 WO2019135954A1 (en) 2018-01-02 2018-12-21 Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023187032A Division JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Publications (4)

Publication Number Publication Date
JP2021508728A JP2021508728A (ja) 2021-03-11
JPWO2019135954A5 true JPWO2019135954A5 (https=) 2022-03-24
JP2021508728A5 JP2021508728A5 (https=) 2022-03-24
JP7378401B2 JP7378401B2 (ja) 2023-11-13

Family

ID=65024141

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020536766A Active JP7378401B2 (ja) 2018-01-02 2018-12-21 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2023187032A Withdrawn JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A Pending JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023187032A Withdrawn JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A Pending JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Country Status (27)

Country Link
US (3) US20200338002A1 (https=)
EP (2) EP4137123A1 (https=)
JP (3) JP7378401B2 (https=)
KR (1) KR102694692B1 (https=)
CN (2) CN115998684A (https=)
AU (1) AU2018399599B2 (https=)
CA (1) CA3087176A1 (https=)
DK (1) DK3735226T3 (https=)
EA (1) EA202091626A1 (https=)
ES (1) ES2927051T3 (https=)
HR (1) HRP20221295T1 (https=)
HU (1) HUE060400T2 (https=)
IL (2) IL275758B2 (https=)
LT (1) LT3735226T (https=)
MA (1) MA51514A (https=)
MD (1) MD3735226T2 (https=)
MX (1) MX2020006992A (https=)
PL (1) PL3735226T3 (https=)
PT (1) PT3735226T (https=)
RS (1) RS63687B1 (https=)
SA (1) SA520412362B1 (https=)
SG (1) SG11202006313WA (https=)
SI (1) SI3735226T1 (https=)
SM (1) SMT202200427T1 (https=)
TW (2) TWI857944B (https=)
UA (1) UA126096C2 (https=)
WO (1) WO2019135954A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3087176A1 (en) * 2018-01-02 2019-07-11 Scynexis, Inc. Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
NZ548195A (en) * 2004-01-14 2011-01-28 Gilead Sciences Inc Lipid-based dispersions useful for drug delivery
JP5245057B2 (ja) 2006-04-03 2013-07-24 メルク・シャープ・アンド・ドーム・コーポレーション 抗真菌剤
CN101861150B (zh) * 2007-09-28 2014-07-16 默克夏普和道赫莫公司 抗真菌制剂
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション
AU2009275230A1 (en) * 2008-07-23 2010-01-28 Targeted Delivery Technologies Limited Methods of administering topical antifungal formulations for the treatment of fungal infections
WO2010019204A1 (en) * 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
ES2593027T3 (es) * 2009-03-30 2016-12-05 Eisai R&D Management Co., Ltd. Composición liposomal
HRP20220544T1 (hr) * 2015-01-19 2022-08-05 Scynexis, Inc. Nove soli i polimorfi scy-078
CA3087176A1 (en) * 2018-01-02 2019-07-11 Scynexis, Inc. Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Similar Documents

Publication Publication Date Title
AU749220B2 (en) Lipid complexes and liposomes of highly insoluble platinum complexes
JP2015098498A (ja) 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
CN1020897C (zh) 用于治疗和预防卡氏肺囊虫肺炎的戊脒盐的制备方法
CN1076614A (zh) 脂质体依太康唑制剂
JP4950890B2 (ja) 動物に対する鉄の送達
JP2021508728A5 (https=)
JPWO2019135954A5 (https=)
JP2025106349A (ja) リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
EP4408472A1 (en) Formulated and/or co-formulated nanocarriers compositions containing immunogenic cell death (icd) inducing prodrugs useful in the treatment of cancer and methods thereof
JP5705978B2 (ja) 溶解度が向上した難溶性トリサイクリック誘導体の薬学的組成物
NZ765771B2 (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
HK40036677A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
CN101056620A (zh) 腹膜内给予以脂质为基质的铂化合物制剂治疗癌症的方法
MXPA99007110A (en) Lipid complexes and liposomes of highly insoluble platinum complexes
HK1194981A (en) Liposome comprising at least one cholesterol derivative
BR102013033866A2 (pt) composições antileishmania contendo o fulerol e uso
JPWO2020176527A5 (https=)